Targeting ADAMTS1/HDAC6 alleviates TGF-β1/SMAD2-associated cardiac fibrosis in cardiac fibrosis post-myocardial infarction
Targeting ADAMTS1/HDAC6 alleviated TGF-β1/SMAD2-associated cardiac fibrosis in CFPMI. This study may provide a novel theoretical basis for the treatment of myocardial fibrosis.
Authors
- Honghui Xu (ORCID: https://orcid.org/0000-0003-4878-2016)
- Qiao Jin
- Lei Li (ORCID: https://orcid.org/0000-0001-8723-3461)
- Shuai Xu (ORCID: https://orcid.org/0000-0001-9928-5437)
- Pengcui Wu
- Luping Jiang
- X Long
- Ran Chen
- Chun Chen
Institutions
- Central South University (CN)
- Changsha Medical University (CN)
- Third Xiangya Hospital (CN)
- University of South China (CN)
Publication Details
- Journal
- Cell Biology and Toxicology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1007/s10565-026-10159-2
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00